Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation

Autor:	Brando Lima, A. C., Machado, A. L., Simon, P., Cavalcante, M. M., Rezende, D. C., Sperandio Da Silva, G. M., Nascimento, P. G. B. D., Quintas, L. E. M., Fernando Queiroz Cunha, Barreiro, E. J., Lima, L. M., Koatz, V. L. G.
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4a25226ea1738b1328210eceb1d0f2f9 http://www.scopus.com/inward/record.url?eid=2-s2.0-80053360549&partnerID=MN8TOARS Zobrazit plný text záznamu